Your browser doesn't support javascript.
loading
Comprehensive Clinicopathologic and Molecular Analysis of Mast Cell Leukemia With Associated Hematologic Neoplasm: A Report and In-Depth Study of 5 Cases.
Li, Philippa; Biancon, Giulia; Patel, Timil; Pan, Zenggang; Kothari, Shalin; Halene, Stephanie; Prebet, Thomas; Xu, Mina L.
Afiliação
  • Li P; Department of Pathology, Yale School of Medicine, New Haven, CT, United States.
  • Biancon G; Section of Hematology, Department of Internal Medicine and Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, United States.
  • Patel T; Section of Hematology, Department of Internal Medicine and Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, United States.
  • Pan Z; Department of Pathology, Yale School of Medicine, New Haven, CT, United States.
  • Kothari S; Section of Hematology, Department of Internal Medicine and Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, United States.
  • Halene S; Section of Hematology, Department of Internal Medicine and Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, United States.
  • Prebet T; Section of Hematology, Department of Internal Medicine and Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, United States.
  • Xu ML; Department of Pathology, Yale School of Medicine, New Haven, CT, United States.
Front Oncol ; 11: 730503, 2021.
Article em En | MEDLINE | ID: mdl-34589432
Mast cell leukemia with associated hematologic neoplasm (MCL-AHN) is a rare and highly aggressive entity that remains understudied due to the paucity of cases. We present a case of a 45-year-old man who was concurrently diagnosed with mast cell leukemia and acute myeloid leukemia. We identified four additional patients who had MCL-AHN in our institution and performed whole-exome sequencing of all available tumors. Our series revealed a novel and identical NR2F6 variant shared among two of the patients. This case series and sequencing results demonstrate the importance of fully characterizing rare tumors that are resistant to treatment.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos